Eli Lilly Grows Social Impact Venture Capital Portfolio to $300M

What You Should Know:

• Today, Eli Lilly and Company announced an additional $50M investment to its now $300 million Social Impact Venture Capital Portfolio. These additional funds will support near- and long-term healthcare solutions for patients in low- and middle-income countries by providing the investment funds needed for the development of new approaches to healthcare challenges.
• Lilly’s Social Impact VC portfolio consists of Lilly 30X30, which aims to improve access to quality healthcare for 30 million people in resource-limited settings annually by 2030, including through the new commitment, as well as Lilly’s Racial Justice Commitment, which aims to decrease the burden of racial injustice and its effects on communities of color.    
• The newly announced funds will leverage Lilly’s resources to invest with purpose, funding positive impacts on people’s lives, livelihoods, health and wellbeing.

What You Should Know:

• Today, Eli Lilly and Company announced an additional $50M investment to its now $300 million Social Impact Venture Capital Portfolio. These additional funds will support near- and long-term healthcare solutions for patients in low- and middle-income countries by providing the investment funds needed for the development of new approaches to healthcare challenges.
• Lilly’s Social Impact VC portfolio consists of Lilly 30X30, which aims to improve access to quality healthcare for 30 million people in resource-limited settings annually by 2030, including through the new commitment, as well as Lilly’s Racial Justice Commitment, which aims to decrease the burden of racial injustice and its effects on communities of color.    
• The newly announced funds will leverage Lilly’s resources to invest with purpose, funding positive impacts on people’s lives, livelihoods, health and wellbeing.